Roberto Bergamaschi

910 total citations
7 papers, 281 citations indexed

About

Roberto Bergamaschi is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, Roberto Bergamaschi has authored 7 papers receiving a total of 281 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 3 papers in Neurology and 2 papers in Oncology. Recurrent topics in Roberto Bergamaschi's work include Multiple Sclerosis Research Studies (6 papers), Peripheral Neuropathies and Disorders (3 papers) and Polyomavirus and related diseases (2 papers). Roberto Bergamaschi is often cited by papers focused on Multiple Sclerosis Research Studies (6 papers), Peripheral Neuropathies and Disorders (3 papers) and Polyomavirus and related diseases (2 papers). Roberto Bergamaschi collaborates with scholars based in Italy, United Kingdom and United States. Roberto Bergamaschi's co-authors include Vittorio Cosi, Roberto Furlan, Diego Franciotta, Elisabetta Zardini, Laura Andreoni, Gianvito Martino, Maurizio Versino, Roberto Poli, A. Romani and Luigina Guasti and has published in prestigious journals such as Journal of the American College of Cardiology, Annals of Neurology and Journal of Neuroimmunology.

In The Last Decade

Roberto Bergamaschi

5 papers receiving 274 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roberto Bergamaschi Italy	4	171	85	70	61	57	7	281
N. P. Robertson United Kingdom	7	250 1.5×	42 0.5×	46 0.7×	49 0.8×	84 1.5×	18	368
Adrian Pace United Kingdom	8	114 0.7×	56 0.7×	46 0.7×	88 1.4×	118 2.1×	16	331
I. D. Stolyarov Russia	7	221 1.3×	112 1.3×	81 1.2×	26 0.4×	99 1.7×	26	361
Robert A Bermel United States	7	271 1.6×	39 0.5×	63 0.9×	28 0.5×	124 2.2×	12	349
Ciro Florio Italy	8	142 0.8×	107 1.3×	43 0.6×	15 0.2×	44 0.8×	12	270
David K. Li Canada	7	169 1.0×	32 0.4×	48 0.7×	19 0.3×	119 2.1×	9	332
Nicolas Dubuisson Belgium	11	147 0.9×	66 0.8×	68 1.0×	23 0.4×	63 1.1×	23	364
Maria Roberta Bongioanni Italy	8	190 1.1×	61 0.7×	95 1.4×	10 0.2×	93 1.6×	11	280
Shaul Kadosh United States	6	333 1.9×	65 0.8×	70 1.0×	16 0.3×	191 3.4×	11	430
Jen-Jen Su Taiwan	6	101 0.6×	83 1.0×	37 0.5×	15 0.2×	76 1.3×	17	321

Countries citing papers authored by Roberto Bergamaschi

Since Specialization

Citations

This map shows the geographic impact of Roberto Bergamaschi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Bergamaschi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Bergamaschi more than expected).

Fields of papers citing papers by Roberto Bergamaschi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Bergamaschi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Bergamaschi. The network helps show where Roberto Bergamaschi may publish in the future.

Co-authorship network of co-authors of Roberto Bergamaschi

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Bergamaschi. A scholar is included among the top collaborators of Roberto Bergamaschi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Bergamaschi. Roberto Bergamaschi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Muraro, Paolo A., Antonio Zito, Alessio Signori, et al.. (2025). Effectiveness of Autologous Hematopoietic Stem Cell Transplantation versus Alemtuzumab and Ocrelizumab in Relapsing Multiple Sclerosis: A Single Center Cohort Study. Annals of Neurology. 98(2). 294–307. 4 indexed citations

2.

Prosperini, Luca, et al.. (2025). Cost-Consequence Analysis of Natalizumab Compared with Other High-Efficacy Treatments in Patients with Relapsing–Remitting Multiple Sclerosis. PharmacoEconomics. 43(12). 1463–1477.

3.

Provenzano, Aldesia, et al.. (2025). Cost-Consequences of Cladribine Tablets for the Treatment of Highly Active Relapsing–Remitting Multiple Sclerosis in Italy. Neurology and Therapy. 14(4). 1507–1520.

4.

Ponzio, Michela, et al.. (2024). Economic burden of multiple sclerosis in an Italian cohort of patients on disease-modifying therapy: analysis of disease cost and its components. Journal of Neurology. 272(1). 50–50. 1 indexed citations

5.

Franciotta, Diego, Gianvito Martino, Elisabetta Zardini, et al.. (2001). Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies. Journal of Neuroimmunology. 115(1-2). 192–198. 146 indexed citations

6.

Bergamaschi, Roberto, A. Romani, Maurizio Versino, Roberto Poli, & Vittorio Cosi. (1998). Clinical aspects of fatigue in multiple sclerosis.. PubMed. 12(5). 247–51. 100 indexed citations

7.

Falcone, Colomba, Luigina Guasti, Silvia Codega, et al.. (1993). Beta-endorphins during coronary angioplasty in patients with silent or symptomatic myocardial ischemia. Journal of the American College of Cardiology. 22(6). 1614–1620. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact